Glutamine-donor peptides

Z-Gln-Gly-CAD-DNS



Order
Quantity
Price
Status
25 mg 175 € available
100 mg 400 € available


Documents
Art. No. C002
Synonym 1-N-(Benzyloxocarbonyl-L-Glutaminyl-Glycinyl)-5-N-(5´-N´,N´- dimethylamino-1´-naphtalenesulfonly)diaminopentane
Molecular Formula C32H42N6O7S
Molecular Weight 654.78
Purity by HPLC >95 % (HPLC)
Appearance Green crystalline solid
λEx, max = 335 nm, λEm, max = 550 nm
Solubility 4 mM in DMSO/10 mM hydrochloric acid 1:9
Please note: First dissolve in DMSO, then dilute with 10 mM hydrochloric acid to final concentration. DMSO stock solutions can be stored at -20°C for at least 6 months. To avoid too many freeze-thaw cycles, we strongly recommend storage of aliquots.
Application Fluorescent glutamine donor substrate for transglutaminases
Storage Store at -15 to -25°C, desiccate
Reference(s) Jeitner et al., Anal. Biochem. 2001, 292:198-206
Pasternack et al., Anal. Biochem. 1997, 249:54-60
Note INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS.

Products

  • Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and industry.

News  

  • Dr. Falk Pharma and Zedira announce start of the phase 2b real-life study of ZED1227 for the treatment of Celiac Disease
  • imageDr. Falk Pharma and Zedira announce successful completion of the phase 2a proof-of-concept study of ZED1227 for the treatment of Celiac Disease
  • imageDr. Falk Pharma und Zedira verkünden den erfolgreichen Abschluss der Phase 2a-Studie mit ZED1227 zur Behandlung von Zöliakie
  • imageReversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis
  • imagePress release: Zedira announces ISO 9001:2015 certification

Blog  

  • DZG Aktuell: „Aufruf zur Teilnahme an einer weiteren Wirksamkeitsstudie mit dem Studienmedikament ZED1227“
  • imageDesign of Oral FXIIIa Blockers as Safer Anticoagulants – Mission Impossible?
  • imageMicrobial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering

Events  

  • Gordon Research Conference: Transglutaminases in Human Disease Processes

    12.06.2022 - 17.06.2022
    Mount Snow, USA

  • 19th International Celiac Disease Symposium

    19.10.2022 - 22.10.2022
    Sorrento, Italy